First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.

BACKGROUND:Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse outcomes including preeclampsia, caesarean section, macrosomia, neonatal morbidity and future development of type 2 diabetes in both mother and child. Current selective screening strategies rely...

Full description

Bibliographic Details
Main Authors: Tina Ravnsborg, Sarah Svaneklink, Lise Lotte T Andersen, Martin R Larsen, Dorte M Jensen, Martin Overgaard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0214457
id doaj-dc8ff2a824584377a6caa2849650c7b6
record_format Article
spelling doaj-dc8ff2a824584377a6caa2849650c7b62021-03-03T20:47:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01143e021445710.1371/journal.pone.0214457First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.Tina RavnsborgSarah SvaneklinkLise Lotte T AndersenMartin R LarsenDorte M JensenMartin OvergaardBACKGROUND:Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse outcomes including preeclampsia, caesarean section, macrosomia, neonatal morbidity and future development of type 2 diabetes in both mother and child. Current selective screening strategies rely on clinical risk factors such as age, family history of diabetes, macrosomia or GDM in a previous pregnancy, and they possess a relatively low specificity. Here we hypothesize that novel first trimester protein predictors of GDM can contribute to the current selective screening strategies for early and accurate prediction of GDM, thus allowing for timely interventions. METHODS:A proteomics discovery approach was applied to first trimester sera from obese (BMI ≥27 kg/m2) women (n = 60) in a nested case-control study design, utilizing tandem mass tag labelling and tandem mass spectrometry. A subset of the identified protein markers was further validated in a second set of serum samples (n = 210) and evaluated for their contribution as predictors of GDM in relation to the maternal risk factors, by use of logistic regression and receiver operating characteristic analysis. RESULTS:Serum proteomic profiling identified 25 proteins with significantly different levels between cases and controls. Three proteins; afamin, serum amyloid P-component and vitronectin could be further confirmed as predictors of GDM in a validation set. Vitronectin was shown to contribute significantly to the predictive power of the maternal risk factors, indicating it as a novel independent predictor of GDM. CONCLUSIONS:Current selective screening strategies can potentially be improved by addition of protein predictors.https://doi.org/10.1371/journal.pone.0214457
collection DOAJ
language English
format Article
sources DOAJ
author Tina Ravnsborg
Sarah Svaneklink
Lise Lotte T Andersen
Martin R Larsen
Dorte M Jensen
Martin Overgaard
spellingShingle Tina Ravnsborg
Sarah Svaneklink
Lise Lotte T Andersen
Martin R Larsen
Dorte M Jensen
Martin Overgaard
First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
PLoS ONE
author_facet Tina Ravnsborg
Sarah Svaneklink
Lise Lotte T Andersen
Martin R Larsen
Dorte M Jensen
Martin Overgaard
author_sort Tina Ravnsborg
title First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
title_short First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
title_full First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
title_fullStr First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
title_full_unstemmed First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
title_sort first-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description BACKGROUND:Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse outcomes including preeclampsia, caesarean section, macrosomia, neonatal morbidity and future development of type 2 diabetes in both mother and child. Current selective screening strategies rely on clinical risk factors such as age, family history of diabetes, macrosomia or GDM in a previous pregnancy, and they possess a relatively low specificity. Here we hypothesize that novel first trimester protein predictors of GDM can contribute to the current selective screening strategies for early and accurate prediction of GDM, thus allowing for timely interventions. METHODS:A proteomics discovery approach was applied to first trimester sera from obese (BMI ≥27 kg/m2) women (n = 60) in a nested case-control study design, utilizing tandem mass tag labelling and tandem mass spectrometry. A subset of the identified protein markers was further validated in a second set of serum samples (n = 210) and evaluated for their contribution as predictors of GDM in relation to the maternal risk factors, by use of logistic regression and receiver operating characteristic analysis. RESULTS:Serum proteomic profiling identified 25 proteins with significantly different levels between cases and controls. Three proteins; afamin, serum amyloid P-component and vitronectin could be further confirmed as predictors of GDM in a validation set. Vitronectin was shown to contribute significantly to the predictive power of the maternal risk factors, indicating it as a novel independent predictor of GDM. CONCLUSIONS:Current selective screening strategies can potentially be improved by addition of protein predictors.
url https://doi.org/10.1371/journal.pone.0214457
work_keys_str_mv AT tinaravnsborg firsttrimesterproteomicprofilingidentifiesnovelpredictorsofgestationaldiabetesmellitus
AT sarahsvaneklink firsttrimesterproteomicprofilingidentifiesnovelpredictorsofgestationaldiabetesmellitus
AT liselottetandersen firsttrimesterproteomicprofilingidentifiesnovelpredictorsofgestationaldiabetesmellitus
AT martinrlarsen firsttrimesterproteomicprofilingidentifiesnovelpredictorsofgestationaldiabetesmellitus
AT dortemjensen firsttrimesterproteomicprofilingidentifiesnovelpredictorsofgestationaldiabetesmellitus
AT martinovergaard firsttrimesterproteomicprofilingidentifiesnovelpredictorsofgestationaldiabetesmellitus
_version_ 1714820696398364672